Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer

Clinical trial NCT04191421 · COMPLETED

Trial details

NCT number: NCT04191421
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2020-01-17
Primary completion: 2023-04-05
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.